95 related articles for article (PubMed ID: 9821213)
1. Stability, blood partition, and protein binding of a chemoprotective agent, 2-(allylthio)pyrazine.
Han KS; Woo SJ; Koo CH; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):171-8. PubMed ID: 9821213
[TBL] [Abstract][Full Text] [Related]
2. Stability, blood partition and protein binding of an antifibrotic agent, oltipraz.
Bu SC; Kim EJ; Kim SH; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):333-44. PubMed ID: 12889516
[TBL] [Abstract][Full Text] [Related]
3. Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
Lee MH; Kim HJ; Kim SH; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):361-70. PubMed ID: 12889527
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous administration to rabbits.
Han KS; Woo SJ; Koo CH; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):29-34. PubMed ID: 9644716
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative.
Moon YJ; Kim SH; Ryu CK; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):167-77. PubMed ID: 11913709
[TBL] [Abstract][Full Text] [Related]
6. Stability, blood partition and plasma protein binding of ipriflavone, an isoflavone derivative.
Kim SH; Lee JS; Lee MG
Biopharm Drug Dispos; 1999 Oct; 20(7):355-60. PubMed ID: 10760844
[TBL] [Abstract][Full Text] [Related]
7. Stability, blood partition, and protein binding of NQ12, a new naphthoquinone derivative.
Kim SH; Kim HJ; Ryu CK; Lee MG
Res Commun Mol Pathol Pharmacol; 1999; 104(2):165-72. PubMed ID: 10634309
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent.
Lee WI; Yoon WH; Park JH; Lee JW; Shim CK; Lee MG
Biopharm Drug Dispos; 1995 Dec; 16(9):775-89. PubMed ID: 8580401
[TBL] [Abstract][Full Text] [Related]
11. Stability, blood partition, and protein binding of DA-5018, a new nonnarcotic analgesic.
Shim HJ; Lee JJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):97-108. PubMed ID: 8824935
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Han KS; Lee MG
Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic changes of intravenous 2-(allylthio) pyrazine, a chemoprotective agent, in rats with acute renal failure induced by uranyl nitrate.
Lee EJ; Kim EJ; Kim YG; Chung HC; Kim SH; Kim DH; Lee I; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):225-36. PubMed ID: 15244038
[TBL] [Abstract][Full Text] [Related]
14. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
Kim SH; Kim WB; Lee MG
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):347-62. PubMed ID: 8746482
[TBL] [Abstract][Full Text] [Related]
15. Influence of albumin concentration, albumin species, pH and temperature on the stereoselectively different binding of (S)-(+)- and (R)-(-)-1-methyl-5-phenyl-5-propyl-barbiturate to serum albumin.
Büch HP; Knabe J; Krug R
Arzneimittelforschung; 1995 Oct; 45(10):1049-53. PubMed ID: 8595055
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee HS; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):275-86. PubMed ID: 11913718
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.
Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2000 Oct; 21(7):285-91. PubMed ID: 11512128
[TBL] [Abstract][Full Text] [Related]
18. Distribution of methotrexate in human blood in vitro: independence of temperature, pH and drug concentration.
Slørdal L; Aarbakke J
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):417-20. PubMed ID: 3654033
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacins from Ecballium elaterium juice increase the binding of bilirubin and ibuprofen to albumin in human plasma.
Greige-Gerges H; Khalil RA; Mansour EA; Magdalou J; Chahine R; Ouaini N
Chem Biol Interact; 2007 Aug; 169(1):53-62. PubMed ID: 17601519
[TBL] [Abstract][Full Text] [Related]
20. Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis.
Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
Chirality; 1998; 10(3):223-8. PubMed ID: 9499573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
